Overview

Cognitive Enhancement in Bipolar Disorder

Status:
Completed

Trial end date:
2011-04-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to examine whether the medication pramipexole (Mirapex) may be able to improve cognitive problems (i.e. difficulties with thinking, memory, and concentration) that may be associated with bipolar disorder.

Phase:

Phase 4

Details

Lead Sponsor:

Northwell Health

Collaborator:

Stanley Medical Research Institute

Treatments:

Pramipexole